Geriatric nursing (New York, N.Y.) · 2026
Non-pharmacological interventions for older adults with comorbid hypertension and type 2 diabetes: A systematic review of randomized controlled trials.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Guanzhou, Song Weijing, Xue Naifei, Zhao Hairan, Ma Yizhou, Zhang Tianyue, Wei Jingyi, Sun Lixin, Hertz Julian T, Yap Mei Chen, Xiong Shangzhi, Yang Lu, Yin Xuejun, Bao Peng, Gong Enying, Li Yanming, Yan Lijing L
Аннотация
BACKGROUND: Multimorbidity is rising and comorbid hypertension and type 2 diabetes is the most common among older adults. Although pharmacological therapy is the mainstay, non-pharmaceutical interventions are essential for disease control. We conducted a systematic review to synthesize evidence from randomized controlled trials in older adults on non-pharmacological approaches by intervention strategy and delivery setting.
METHODS: Following PRISMA 2020, we searched PubMed, Embase, and Cochrane CENTRAL (until October 2024) for randomized controlled trials enrolling adults ≥60 years with both conditions. Risk of bias was assessed with RoB 2; heterogeneity precluded meta-analysis and findings were synthesized narratively.
RESULTS: A total of 3449 studies were screened, and 16 trials were included in final analyses. Interventions were classified as exercise (n = 3), diet (n = 2), self-monitoring (n = 1), multi-strategy (n = 3), or comprehensive lifestyle modification (n = 7), delivered via hospital (n = 6), community (n = 6), or telehealth (n = 4) models. Most trials (∼75%) reported a statistically significant effect on their prespecified primary outcomes, mainly blood pressure or HbA1c. Effects were most consistent for comprehensive lifestyle modification, especially those combining individualized planning with technology-assisted support. By setting, hospital interventions tended to yield short-term physiological gains, whereas community and telehealth models emphasized adherence and sustained engagement. Only two trials included post-intervention follow-up.
CONCLUSION: Comprehensive behaviorally informed interventions combining individualized planning with technology-assisted support were the most effective for older adults with hypertension and diabetes multimorbidity. Studies targeting this population remain limited with no long-term follow-up. Innovations in strategy optimization and adaptation to contexts and assessment of sustained effects are needed in multimorbidity management.
METHODS: Following PRISMA 2020, we searched PubMed, Embase, and Cochrane CENTRAL (until October 2024) for randomized controlled trials enrolling adults ≥60 years with both conditions. Risk of bias was assessed with RoB 2; heterogeneity precluded meta-analysis and findings were synthesized narratively.
RESULTS: A total of 3449 studies were screened, and 16 trials were included in final analyses. Interventions were classified as exercise (n = 3), diet (n = 2), self-monitoring (n = 1), multi-strategy (n = 3), or comprehensive lifestyle modification (n = 7), delivered via hospital (n = 6), community (n = 6), or telehealth (n = 4) models. Most trials (∼75%) reported a statistically significant effect on their prespecified primary outcomes, mainly blood pressure or HbA1c. Effects were most consistent for comprehensive lifestyle modification, especially those combining individualized planning with technology-assisted support. By setting, hospital interventions tended to yield short-term physiological gains, whereas community and telehealth models emphasized adherence and sustained engagement. Only two trials included post-intervention follow-up.
CONCLUSION: Comprehensive behaviorally informed interventions combining individualized planning with technology-assisted support were the most effective for older adults with hypertension and diabetes multimorbidity. Studies targeting this population remain limited with no long-term follow-up. Innovations in strategy optimization and adaptation to contexts and assessment of sustained effects are needed in multimorbidity management.